An imaging technique called 18F-FAPI PET may be able to detect the earliest signs of changes in blood vessel tissues…
Articles by Marisa Wexler, MS
Using in-depth analyses and machine learning, scientists have identified several molecules and genes involved in metabolism that may be diagnostic…
Sildenafil is generally more effective than bosentan at controlling blood pressure and reducing the need for supplemental oxygen in infants…
High levels of a small RNA molecule in the blood may be a marker of pulmonary arterial hypertension (PAH)…
A Phase 2 clinical trial of TX45, Tectonic Therapeutic’s investigational therapy for pulmonary hypertension and heart failure…
Adding Uptravi (selexipag) to standard-of-care therapy within six months of starting treatment may reduce the risk of hospitalization and…
Treatments that target the prostacyclin pathway hold promise as chronic thromboembolic pulmonary hypertension (CTEPH) treatment for patients who aren’t…
The Pulmonary Hypertension Association (PHA) is fundraising and advocating with a campaign called “Let Your Light Shine” this November…
Researchers at Monash University in Australia will use newly granted funding to advance their work on a project that aims…
An upcoming clinical trial will test whether empagliflozin, a drug widely approved to treat diabetes and heart failure, might…
For people with pulmonary arterial hypertension (PAH) both with and without a few co-occurring heart problems, combination therapy with…
The U.S. Food and Drug Administration has given Tectonic Therapeutic the go-ahead to start a Phase 2 clinical…